BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.420
EU - Europa 833
AS - Asia 640
SA - Sud America 14
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.408
SE - Svezia 281
HK - Hong Kong 280
SG - Singapore 195
CN - Cina 115
GB - Regno Unito 115
IT - Italia 96
BG - Bulgaria 90
DE - Germania 76
FI - Finlandia 33
BE - Belgio 22
IE - Irlanda 22
FR - Francia 18
CA - Canada 12
CZ - Repubblica Ceca 11
UA - Ucraina 11
AT - Austria 10
ID - Indonesia 9
IR - Iran 8
LT - Lituania 8
MY - Malesia 7
TR - Turchia 7
NL - Olanda 6
VN - Vietnam 6
CL - Cile 5
JP - Giappone 5
NO - Norvegia 5
RO - Romania 5
BR - Brasile 4
EG - Egitto 4
ES - Italia 4
PL - Polonia 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DK - Danimarca 3
IN - India 3
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
MD - Moldavia 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CO - Colombia 1
GR - Grecia 1
HU - Ungheria 1
KZ - Kazakistan 1
PE - Perù 1
TN - Tunisia 1
Totale 4.917
Salva come PNG Salva come JPEG
Città #
Fairfield 552
Chandler 548
Ashburn 339
Hong Kong 279
Nyköping 255
Woodbridge 207
Houston 191
Wilmington 188
Cambridge 158
Seattle 157
Ann Arbor 147
Singapore 141
San Diego 111
Princeton 90
Sofia 90
Southend 41
Bremen 33
Helsinki 32
Dearborn 28
London 27
New York 24
Beijing 22
Brussels 22
Shanghai 22
Dublin 21
Brno 11
Norwalk 11
Bologna 10
Jacksonville 9
Jakarta 9
Kilburn 9
Toronto 9
Vienna 9
Des Moines 8
Modena 8
Milan 7
Augusta 6
Chiswick 6
Dong Ket 6
Eugene 6
Grafing 6
Izmir 6
Phoenix 6
Rome 6
San Mateo 6
Frankfurt am Main 5
Leawood 5
Paris 5
Redwood City 5
San Francisco 5
Amsterdam 4
Dallas 4
Fremont 4
Hangzhou 4
Wuhan 4
Buenos Aires 3
Duncan 3
Falls Church 3
Hefei 3
Kunming 3
Prescot 3
Turin 3
Ardabil 2
Berlin 2
Boardman 2
Chengdu 2
Chisinau 2
Costigliole Saluzzo 2
Florence 2
Hiroshima 2
Hounslow 2
Islington 2
Jinan 2
Minsk 2
Montegranaro 2
Nanjing 2
Oslo 2
Romainville 2
Saint Louis 2
Tokyo 2
Trento 2
Acton 1
Almaty 1
Almere Stad 1
Andover 1
Boca Raton 1
Boston 1
Brasov 1
Brierley Hill 1
Budapest 1
Cairo 1
Cesano Maderno 1
Charleston 1
Charlotte 1
Chicago 1
Ciampino 1
Clearwater 1
Como 1
Cordovado 1
Cupertino 1
Totale 4.002
Salva come PNG Salva come JPEG
Nome #
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 212
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 193
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 163
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 162
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 133
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 127
Adaptive response in Hepatitis B virus infection 86
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 77
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 75
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 74
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 73
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 68
Chronic hepatitis B: Are we close to a cure? 67
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 67
Liver transplantation for patients with alcoholic liver disease: an open question 66
Stem cell mobilization and collection in patients with liver cirrhosis 66
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 66
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 66
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 63
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 62
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 62
Alcohol and viral hepatitis: a mini-review 62
Hepatitis B virus and immune response 61
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 60
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 59
CD 133+ stem cells for the treatment of end stage liver disease 58
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 58
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 57
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 56
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 56
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 56
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 55
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 55
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 54
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 54
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 53
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 53
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 52
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 52
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 52
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 52
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 52
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 51
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 51
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 51
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 50
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 50
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 50
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 49
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 49
Bone marrow derived stem cells for the treatment of end-stage liver disease 49
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 48
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 48
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 48
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 47
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 46
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 46
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 45
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 45
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 44
Vitamins in the treatment of chronic viral hepatitis 43
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 42
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 42
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 41
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 40
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 40
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 39
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 39
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 37
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 37
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 36
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 36
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 36
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 36
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 34
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 34
Stem cells for end stage liver disease: How far have we got? 33
Trattamento dell’epatopatia alcolica 32
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 32
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 30
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 27
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 26
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 26
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 25
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 25
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 25
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 24
MARS and Prometheus: our clinical experience in acute chronic liver failure 21
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 20
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 19
Totale 5.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020245 0 0 0 20 30 46 56 34 27 9 18 5
2020/2021860 17 10 10 20 15 31 10 20 396 30 272 29
2021/20221.484 257 134 48 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/2025158 117 23 6 12 0 0 0 0 0 0 0 0
Totale 5.039